Hypoxia-induced CTCF mediates alternative splicing via coupling chromatin looping and RNA Pol II pause to promote EMT in breast cancer
Parik KakaniiD, Shruti Ganesh DhamdhereiD, Deepak PantiD, Rushikesh Joshi, Sachin MishraiD, Anchala PandeyiD, Dimple NotaniiD, Sanjeev ShuklaiD
Abstract
Cancer cells experiencing hypoxic stress employ Epithelial-Mesenchymal Transition (EMT) to undergo metastasis through rewiring chromatin landscape, epigenetics, and importantly alternative splicing. Here, we investigated the role of CTCF, chromatin, epigenetic and alternative splicing modulator under hypoxia to promote EMT. Our result shows that hypoxia-induced epigenetic changes upregulate CTCF expression in breast cancer. We delineate that CTCF is a direct target of HIF1 and the hypoxia-induced HIF1-CTCF axis functionally contributes to promoting EMT in breast cancer cells. Finally, our work uncovers COL5A1, an EMT gene, as a direct target of CTCF. We demonstrated that hypoxia-mediated CTCF enrichment on COL5A1 promoter regulates expression as well as alternative splicing events to promote EMT. Here, we put forward an intricate mechanism of alternative splicing where CTCF-mediated promoter-exon upstream looping regulates DNA de-methylation and CTCF-mediated RNA Pol II pausing at COL5A1 exon 64A. Our global analysis of CTCF-ChIP-seq data reveals that the hypoxia-induced differential CTCF occupancy possibly regulates gene expression and alternative splicing events of many genes that are enriched in the EMT pathway, cancer cell motility and invasion, angiogenesis, and stemness under hypoxia, similarly to the proposed model. Finally, we employed the epigenetic modulator dCas9-DNMT3A system to specifically disrupt HIF1 or CTCF binding under hypoxia and hence the HIF1-CTCF-COL5A1exon64A axis that alleviates the EMT potential of breast cancer cells that may represent a novel therapeutic target in breast cancer. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=180 SRC="FIGDIR/small/539689v1_ufig1.gif" ALT="Figure 1"> View larger version (35K): org.highwire.dtl.DTLVardef@e15c15org.highwire.dtl.DTLVardef@1649a71org.highwire.dtl.DTLVardef@1d77481org.highwire.dtl.DTLVardef@21f148_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical AbstractC_FLOATNO C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 12
- FWCI
- 2.99
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PRMT5-mediated histone methylation regulates alternative splicing via MECP2-PTBP1 to promote EMT in breast cancer hypoxia
Srinivas Abhishek Mutnuru, Pooja Yadav, … Sanjeev Shukla·PLoS BiologyPeer-reviewed·Oct 28, 2025
- An ERα-Dependent Hypoxia Response Defines EMT-Adjacent Tumour Regions and Suppresses the Pro-survival Effects of Amiloride in Estrogen Receptor-Positive Breast Cancer
Jodie R. Malcolm, Jack Stenning, … Andrew N. Holding·bioRxiv·Oct 3, 2025
- Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform.
Jordan Quenneville, Albert Feghaly, … Étienne Gagnon·Cancer Gene TherapyPeer-reviewed·Jul 8, 2024
- A CTCF-LDHB axis converts nuclear lactate availability into an H3K18 acylation switch that directs alternative splicing in hypoxic breast cancer
Parik Kakani, Abhisek Brahma, … Sanjeev Shukla·bioRxiv·Oct 29, 2026
- Hypoxia-induced histone methylation and NF-κB activation in pancreas cancer fibroblasts promote EMT-supportive growth factor secretion
Karl M. Kowalewski, Sara J. Adair, … Matthew J. Lazzara·bioRxiv·Jan 30, 2025
- P4HA2: A link between tumor-intrinsic hypoxia, partial EMT and collective migration
V. Aggarwal, S. Sahoo, … S. Sant·bioRxiv·Feb 28, 2022